Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 200 | 3 | ONCOLOGY//PACLITAXEL//THYMIDYLATE SYNTHASE | 52806 |
| 978 | 2 | 5 FLUOROURACIL//DIHYDROPYRIMIDINE DEHYDROGENASE//THYMIDINE PHOSPHORYLASE | 10904 |
| 22461 | 1 | DIPYRIDAMOLE//DIPYRIDAMOLE DERIVATIVES//PHARMACOL TOXICOL CANC AOBA KU | 403 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | DIPYRIDAMOLE | authKW | 1252746 | 30% | 13% | 122 |
| 2 | DIPYRIDAMOLE DERIVATIVES | authKW | 312819 | 1% | 100% | 4 |
| 3 | PHARMACOL TOXICOL CANC AOBA KU | address | 156409 | 0% | 100% | 2 |
| 4 | TUMOR CELL GROWTH AND VIABILITY | authKW | 117304 | 1% | 50% | 3 |
| 5 | AGGRENOX R | authKW | 104272 | 0% | 67% | 2 |
| 6 | DNA SYNTHESIS AND FRAGMENTATION | authKW | 104272 | 0% | 67% | 2 |
| 7 | PHOTOBIOCHEMISTRY | authKW | 104272 | 0% | 67% | 2 |
| 8 | 2 CL AD 2 CHLORO ADENOSINE | authKW | 78205 | 0% | 100% | 1 |
| 9 | 2 TISIOL MALATTIE PARATO P CLIN | address | 78205 | 0% | 100% | 1 |
| 10 | 2ND ORDER DERIVATIVE UV SPECTROPHOTOMETRY | authKW | 78205 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 942 | 26% | 0% | 106 |
| 2 | Pharmacology & Pharmacy | 830 | 28% | 0% | 112 |
| 3 | Chemistry, Analytical | 234 | 12% | 0% | 47 |
| 4 | Peripheral Vascular Diseases | 106 | 5% | 0% | 22 |
| 5 | Hematology | 67 | 5% | 0% | 19 |
| 6 | Virology | 27 | 2% | 0% | 10 |
| 7 | Biophysics | 25 | 4% | 0% | 16 |
| 8 | Biochemistry & Molecular Biology | 22 | 11% | 0% | 44 |
| 9 | Biochemical Research Methods | 18 | 3% | 0% | 13 |
| 10 | Cardiac & Cardiovascular System | 18 | 4% | 0% | 16 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | PHARMACOL TOXICOL CANC AOBA KU | 156409 | 0% | 100% | 2 |
| 2 | 2 TISIOL MALATTIE PARATO P CLIN | 78205 | 0% | 100% | 1 |
| 3 | ANTICANCER MOL ONCOL | 78205 | 0% | 100% | 1 |
| 4 | KINET CHEM BIOL REACT | 78205 | 0% | 100% | 1 |
| 5 | MED SURG SCI BIOTECHNOL INTERNAL MED | 78205 | 0% | 100% | 1 |
| 6 | MEDFRANZ VOLHARD CARDIOVASC CLIN | 78205 | 0% | 100% | 1 |
| 7 | MOL TOXICOL G120 | 78205 | 0% | 100% | 1 |
| 8 | PHARMACOL EGIDIO MENEGHETTI | 78205 | 0% | 100% | 1 |
| 9 | VASC BIOL ATHEROTHROMBOSIS MASS SPE OMETRY LA | 78205 | 0% | 100% | 1 |
| 10 | VET AFFAIR SALT LAKE CITY HEALTHCARE SYST | 78205 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1486 | 3% | 0% | 12 |
| 2 | CANCER RESEARCH | 850 | 5% | 0% | 21 |
| 3 | CANCER COMMUNICATIONS | 765 | 0% | 1% | 1 |
| 4 | BIOCHEMICAL PHARMACOLOGY | 690 | 3% | 0% | 13 |
| 5 | ANTICANCER RESEARCH | 660 | 3% | 0% | 13 |
| 6 | ACTA VIROLOGICA | 596 | 1% | 0% | 4 |
| 7 | ANTI-CANCER DRUGS | 576 | 1% | 0% | 5 |
| 8 | ADVANCES IN CARDIOLOGY | 573 | 0% | 1% | 1 |
| 9 | ADVANCES IN ENZYME REGULATION | 521 | 0% | 0% | 2 |
| 10 | THROMBOSIS AND HAEMOSTASIS | 483 | 2% | 0% | 8 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |